Ignite Creation Date:
2024-05-06 @ 1:40 PM
Last Modification Date:
2024-10-26 @ 1:17 PM
Study NCT ID:
NCT04082507
Status:
UNKNOWN
Last Update Posted:
2019-09-09
First Post:
2019-08-29
Brief Title:
Maternal Serum Alpha-fetoprotein Level May Predict the Presence of Morbid Adherent Placenta
Sponsor:
rasha medhat abdul-hady
Organization:
Ain Shams University
Study Overview
Official Title:
Alpha-fetoprotein as a Biochemical Marker in Prediction of Placenta Acreta Increta Percreta
Status:
UNKNOWN
Status Verified Date:
2019-09
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to compare between alpha-fetoproteine as a biological marker and between ultrasound and Doppler in prediction of morbid adherent placenta
Detailed Description:
in pregnant women withe previous cesarean section placenta previa and ultrasonographic finding of an abnormally adherent placenta dose maternal serum alpha-fetoprotein predict prenataly the presence of morbid adherent placenta accurately
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None